The Effect of Ablation Therapy on Barrett's Esophagus

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT00587314
Status
Enrolling By Invitation

Conditions

  • Barrett's Esophagus
  • Early Esophageal Adenocarcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Biopsy — OTHER
    Biopsies for research purposes will be obtained when returning for clinically indicated surveillance of Barrett's Esophagus

Study Details

To assess the effect of ablative therapy (Photodynamic Therapy or Radiofrequency ablation ) on Barrett's Esophagus

Key Dates

Start date
Jan 31, 2004
Status verified
Mar 2026
Primary completion
Jan 31, 2029
Completion
Jan 31, 2029

Study Design

Enrollment
600 participants (estimated)

Arms

  • Arm: 1
    Patients with Barrett's Esophagus or early esophageal adenocarcinoma who will or have had ablation therapy will be enrolled in this long term follow up study

Primary Outcome Measure

Response to treatment [ Time Frame: at time of surveillance intervals ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905-

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN

Related Studies